10x Genomics TXG recently unveiled Atera, a next-generation in situ spatial biology platform designed to deliver ...

10x Genomics’ facility at 5500 Stoneridge Mall Road Pleasanton, CA, one of the company’s three sites in the San Francisco suburb. 10x Genomics has joined with two licensor partners to administer a ...

PLEASANTON, Calif., April 18, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...

With a trio of partnership announcements this month, 10x Genomics has signaled it is looking beyond its traditional focus on research tools for academic, government, and industry customers, by ...

Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to ...

Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path for Blood Disorder Diagnosis, complementing bone marrow ...

10x Genomics is stepping up to buy Scale Biosciences and its single-cell profiling solutions, with plans to implement them within the company’s Chromium platform. The deal for the recent Fierce ...

Single-cell sequencing is useful for a number of applications. For example, it can reveal cellular heterogeneity inside complex tissues, such as tumors. It can also provide information about how ...

Kelly Parliament, staff application scientist at Beckman Coulter Life Sciences, discusses how automation is improving the efficiency of single-cell transcriptomic workflows.